<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(3)</volume><submitter>Gao F</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To study whether luteal phase stimulation provides clinical and embryological outcomes comparable to follicular phase stimulation in controlled ovarian hyperstimulation cycles.&lt;h4>Design&lt;/h4>Retrospective cohort study.&lt;h4>Subjects&lt;/h4>A total of 12,442 patients undergoing 18,062 in vitro fertilization cycles between January 1, 2018, and December 21, 2021, across 6 assisted reproductive technology centers within a large US fertility network.&lt;h4>Exposure&lt;/h4>Patients underwent controlled ovarian hyperstimulation using either follicular phase or luteal phase initiation. Cycles involving fresh transfers, day 3 transfers, or poor endometrial receptivity were excluded.&lt;h4>Main outcome measures&lt;/h4>The primary outcomes were clinical pregnancy rates and cumulative live birth rate</pubmed_abstract><journal>F&amp;S reports</journal><pagination>289-298</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12496433</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Comparable Clinical and Embryological Outcomes in Luteal and Follicular Phase Controlled Ovarian Hyperstimulation: A Retrospective Cohort Study.</pubmed_title><pmcid>PMC12496433</pmcid><pubmed_authors>Baxter K</pubmed_authors><pubmed_authors>Mascaros Martinez JM</pubmed_authors><pubmed_authors>Garrido N</pubmed_authors><pubmed_authors>Gao F</pubmed_authors><pubmed_authors>Kort J</pubmed_authors><pubmed_authors>Whitehead C</pubmed_authors><pubmed_authors>Badamjav O</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparable Clinical and Embryological Outcomes in Luteal and Follicular Phase Controlled Ovarian Hyperstimulation: A Retrospective Cohort Study.</name><description>&lt;h4>Objective&lt;/h4>To study whether luteal phase stimulation provides clinical and embryological outcomes comparable to follicular phase stimulation in controlled ovarian hyperstimulation cycles.&lt;h4>Design&lt;/h4>Retrospective cohort study.&lt;h4>Subjects&lt;/h4>A total of 12,442 patients undergoing 18,062 in vitro fertilization cycles between January 1, 2018, and December 21, 2021, across 6 assisted reproductive technology centers within a large US fertility network.&lt;h4>Exposure&lt;/h4>Patients underwent controlled ovarian hyperstimulation using either follicular phase or luteal phase initiation. Cycles involving fresh transfers, day 3 transfers, or poor endometrial receptivity were excluded.&lt;h4>Main outcome measures&lt;/h4>The primary outcomes were clinical pregnancy rates and cumulative live birth rate</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-04T03:17:08.073Z</modification><creation>2026-06-04T03:06:38.324Z</creation></dates><accession>S-EPMC12496433</accession><cross_references><pubmed>41054724</pubmed><doi>10.1016/j.xfre.2025.06.008</doi></cross_references></HashMap>